Australia markets closed

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
237.59-3.94 (-1.63%)
At close: 04:00PM EST
239.56 +1.97 (+0.83%)
After hours: 06:07PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 68.28B
Enterprise value 106.76B
Trailing P/E 13.65
Forward P/E 13.26
PEG ratio (5-yr expected) 1.35
Price/sales (ttm)1.22
Price/book (mrq)N/A
Enterprise value/revenue 1.79
Enterprise value/EBITDA 8.54

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 3-0.83%
S&P500 52-week change 3-15.89%
52-week high 3279.02
52-week low 3164.47
50-day moving average 3217.52
200-day moving average 3216.70

Share statistics

Avg vol (3-month) 31.48M
Avg vol (10-day) 31.08M
Shares outstanding 5282.72M
Implied shares outstanding 6N/A
Float 8210M
% held by insiders 125.45%
% held by institutions 166.79%
Shares short (14 Nov 2022) 43.2M
Short ratio (14 Nov 2022) 41.83
Short % of float (14 Nov 2022) 41.52%
Short % of shares outstanding (14 Nov 2022) 41.13%
Shares short (prior month 13 Oct 2022) 43.24M

Dividends & splits

Forward annual dividend rate 42.24
Forward annual dividend yield 40.95%
Trailing annual dividend rate 32.16
Trailing annual dividend yield 30.89%
5-year average dividend yield 4N/A
Payout ratio 412.20%
Dividend date 327 Dec 2022
Ex-dividend date 412 Dec 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 8.99%
Operating margin (ttm)15.09%

Management effectiveness

Return on assets (ttm)11.17%
Return on equity (ttm)1,183.00%

Income statement

Revenue (ttm)59.8B
Revenue per share (ttm)201.03
Quarterly revenue growth (yoy)-2.00%
Gross profit (ttm)22.49B
EBITDA 11.97B
Net income avi to common (ttm)5.38B
Diluted EPS (ttm)17.70
Quarterly earnings growth (yoy)-50.00%

Balance sheet

Total cash (mrq)1.12B
Total cash per share (mrq)3.97
Total debt (mrq)39.47B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.38
Book value per share (mrq)-11.87

Cash flow statement

Operating cash flow (ttm)8.44B
Levered free cash flow (ttm)3.61B